CLINICAL_TRIALS
trial_result
· 2023-08-01
Clinical Trial Update: Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma [Phase 2]
Summary
Phase 2 clinical trial update on anlotinib as maintenance treatment for advanced soft tissue sarcoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Yat-sen University | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN